Precipio EV/EBITDA Ratio 2011-2026 | PRPO

Annual EV/EBITDA Ratio Precipio

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
988	-12.8	-1.7	-0.213	-1.8	-5.62	-1.35	-1.1	-1.53	-3.15	-1.73	-2.27	-	-	-	-6.41	5.4	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
988	-12.8	68.1

EV/EBITDA Ratio of other stocks in the Diagnostics research industry

Issuer	EV/EBITDA Ratio	Price	% 24h	Market Cap	Country
Enzo Biochem ENZ	2.04	-	-8.98 %	$ 14.8 K	USA
Centogene N.V. CNTG	0.387	-	-6.23 %	$ 30.6 M	Germany
Heska Corporation HSKA	-134	-	-	$ 1.31 B	USA
Celcuity CELC	-32.4	$ 88.28	-4.53 %	$ 4.13 B	USA
Akumin AKU	23.4	-	-17.87 %	$ 25.9 M	Canada
Co-Diagnostics CODX	0.0391	$ 5.63	-2.26 %	$ 7.49 M	USA
Castle Biosciences CSTL	-227	$ 21.01	-2.73 %	$ 609 M	USA
Fulgent Genetics FLGT	-8.71	$ 19.15	-1.79 %	$ 589 M	USA
Aspira Women's Health AWH	-1.36	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	-2.05	-	-61.36 %	$ 2.46 M	USA
Guardant Health GH	-38.2	$ 125.61	-5.6 %	$ 15.7 B	USA
Biocept BIOC	-26.9	-	-13.05 %	$ 7.29 M	USA
Interpace Biosciences IDXG	3.62	$ 1.67	-6.7 %	$ 7.39 M	USA
Oxford Immunotec Global PLC OXFD	-73.4	-	-	$ 562 M	Britain
Illumina ILMN	22.1	$ 162.32	-3.42 %	$ 25.2 B	USA
CareDx, Inc CDNA	-100	$ 22.25	-3.76 %	$ 1.19 B	USA
Chembio Diagnostics CEMI	-1.86	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	0.000843	-	-	$ 9.42 M	Israel
ICON Public Limited Company ICLR	20	$ 149.45	-2.19 %	$ 11.7 B	Irlanda
HTG Molecular Diagnostics HTGM	-0.156	-	-20.0 %	$ 1.06 M	USA
Lantheus Holdings LNTH	15.5	$ 100.98	-1.79 %	$ 6.82 B	USA
Global Cord Blood Corporation CO	-4.15	-	-	$ 399 M	China
Fluidigm Corporation FLDM	-13.6	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	-2.67	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	-2.67	-	0.12 %	$ 80.1 M	China
DermTech DMTK	-2.44	-	-11.32 %	$ 2.94 M	USA
NeoGenomics NEO	-33.5	$ 10.9	-3.63 %	$ 1.4 B	USA
Natera NTRA	-112	$ 215.31	-3.06 %	$ 29.4 B	USA
Charles River Laboratories International CRL	26.6	$ 181.34	-2.4 %	$ 8.99 B	USA
PRA Health Sciences, Inc. PRAH	20.8	-	-	$ 10.7 B	USA
Pacific Biosciences of California PACB	-2.24	$ 1.45	-11.04 %	$ 435 M	USA
Medpace Holdings MEDP	30.7	$ 454.25	-0.97 %	$ 13.1 B	USA
Mettler-Toledo International MTD	627	$ 1 154.33	-2.22 %	$ 23.8 B	Schweiz
Exact Sciences Corporation EXAS	-20.8	-	-	$ 19.8 B	USA
Myriad Genetics MYGN	-1.79	$ 4.57	-2.56 %	$ 423 M	USA
National Research Corporation NRC	14.3	$ 19.14	-3.09 %	$ 428 M	USA
Personalis PSNL	-4.87	$ 10.75	-11.16 %	$ 959 M	USA
Koninklijke Philips N.V. PHG	17.1	$ 26.11	0.46 %	$ 24.8 B	Niderland
Senseonics Holdings SENS	-5.62	$ 6.67	-4.85 %	$ 278 M	USA
QIAGEN N.V. QGEN	13.2	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	186	-	-	$ 2.69 B	USA
Biomerica BMRA	-6.24	$ 2.12	-1.17 %	$ 4.87 M	USA
Laboratory Corporation of America Holdings LH	8.7	$ 265.15	1.6 %	$ 22.1 B	USA
Twist Bioscience Corporation TWST	-23.6	$ 69.22	-6.37 %	$ 4.14 B	USA
Thermo Fisher Scientific TMO	19.3	$ 472.8	-1.91 %	$ 178 B	USA
Trinity Biotech plc TRIB	-15.5	$ 0.67	-2.43 %	$ 241 M	Irlanda
Motus GI Holdings MOTS	-0.0496	-	-34.28 %	$ 263 K	Israel
Waters Corporation WAT	60.2	$ 365.36	-2.95 %	$ 21.8 B	USA
Neogen Corporation NEOG	40.3	$ 8.9	-2.41 %	$ 1.93 B	USA
Quest Diagnostics Incorporated DGX	5.51	$ 200.29	2.13 %	$ 22.2 B	USA